Videos

WuXi AppTec's Felix Hsu on 'Make vs Buy' Decisions

WuXi AppTec's Felix Hsu on 'Make vs Buy' Decisions

The SVP and global head of advanced therapies also talks about cell and gene therapy market trends

06.21.19
At BIO 2019 Contract Pharma had a chance to talk with WuXi AppTecc’s Felix Hsu, SVP and global head of advanced therapies, about “Make vs Buy” decisions as well as cell and gene therapy market trends.
Related Searches:
Suggested For You
WuXi AppTec WuXi AppTec
Catalent CEO Talks Gene Therapy Trends Catalent CEO Talks Gene Therapy Trends
The 20th Annual Salary Survey The 20th Annual Salary Survey
Iovance Expands Partnership with WuXi Advanced Therapies Iovance Expands Partnership with WuXi Advanced Therapies
ChargePoint Technology on Aseptic Mfg. Trends ChargePoint Technology on Aseptic Mfg. Trends
WuXi AppTec Appoints CMO WuXi AppTec Appoints CMO
Solid Dose Processing & Packaging Trends Solid Dose Processing & Packaging Trends
Meeting Bioprocessing Mfg. Capacity Demands Meeting Bioprocessing Mfg. Capacity Demands
Solid Dose Packaging Solid Dose Packaging
Interphex Exhibitor List Interphex Exhibitor List
WuXi AppTec Testing Facilities Complete Inspections WuXi AppTec Testing Facilities Complete Inspections
Manufacturing Equipment Insights Manufacturing Equipment Insights
Pharma Equipment Trends Pharma Equipment Trends
Scott Gottlieb to Resign as FDA Commissioner Scott Gottlieb to Resign as FDA Commissioner
Reed-Lane Makes the Move into Cold Chain Market Reed-Lane Makes the Move into Cold Chain Market

Related Buyers Guide Companies

    Loading, Please Wait..